Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-022068
Filing Date
2021-06-04
Accepted
2021-06-04 17:00:48
Documents
1
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7082
  Complete submission text file 0000899243-21-022068.txt   8666
Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
Templeman Thomas (Reporting) CIK: 0001654274 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 21997204

Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations